Association of chemerin Rs17173608 and vaspin Rs2236242 gene polymorphisms with metabolic syndrome in Egyptian women

Endocrine Research

Volumn 41, Issue 1, 2016, Pages 43-48

  Mehanna, Eman T ^a   Mesbah, Noha M ^a   Ghattas, Maivel H ^b   Saleh, Samy M ^a   Abo Elmatty, Dina M ^a  

^a Suez Canal University   (Egypt)

^b PORT SAID UNIVERSITY   (Egypt)

Author keywords

Adipokines; Chemerin rs17173608; Metabolic syndrome; Polymorphism; Vaspin rs2236242

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; VASPIN; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; CHEMERIN GENE; CONTROLLED STUDY; EGYPTIAN; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VASPIN GENE; ALLELE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; EGYPT; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHEMOKINES; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SERPINS;

EID: 84945208740     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2015.1066802     Document Type: Article

References (40)

1. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
2. Grundy SM, Neeland IJ, Turer AT, Vega GL. Ethnic and gender susceptibility to metabolic risk. Metab Synd Relat Disord 2014;12: 110-16.
3. Roh SG, Song SH, Choi KC, et al. Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007;362:1013-18.
4. Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687-94.
5. Cash JL, Hart R, Russ A, et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008;205: 767-75.
6. Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007;282:28175-88.
7. Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 2005;102:10610-15.
8. Li K, Li L, Yang M, et al. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur J Endocrinol 2011;164:905-10.
9. Esaki E, Adachi H, Hirai Y, et al. Serum vaspin levels are positively associated with carotid atherosclerosis in a general population. Atherosclerosis 2014;233:248-52.
10. Golpaie A, Tajik N, Masoudkabir F, et al. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 2011;22: 181-6.
11. Müssig K, Staiger H, Machicao F, et al. RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. Metabolism 2009;58:519-24.
12. Kempf K, Rose B, Illig T, et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp Clin Endocrinol Diabetes 2010;118:184-9.
13. Hashemi M, Rezaei H, Eskandari-Nasab E, et al. Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene 2012;510:113-17.
14. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
15. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
17. Ramos RG, Olden K. The prevalence of metabolic syndrome among US women of childbearing age. Am J Public Heath 2008;98: 1122-7.
18. Joy T, Lahiry P, Pollex RL, Hegele RA. Genetics of metabolic syndrome. Curr Diabetes Rep 2008;8:141-8.
19. Ghattas MH, Mehanna ET, Mesbah NM, Abo-Elmatty DM. Association of estrogen receptor alpha gene polymorphisms with metabolic syndrome in Egyptian women. Metabolism 2013;62: 1437-42.
20. Gupta V, Gupta A, Jafar T, et al. Association of TNF-alpha promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF-alpha and leptin levels in Indian adult women. Cytokine 2012;57:32-6.
21. Xi B, Ruiter R, Chen J, et al. The ACE insertion/deletion polymorphism and its association with metabolic syndrome. Metabolism 2012;61:891-7.
22. Povel CM, Boer JM, Reiling E, Feskens EJ. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 2011;12: 952-67.
23. Dranse HG, Muruganandan S, Cinal CJ. Investigating novel mechanisms of chemerin signalling in mature adipocytes. FASEB J 2013;27:669.1.
24. Fatima SS, Bozaoglu K, Rehman R, et al. Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. PLoS One 2013;8:e57113.
25. Shin HY, Lee DC, Chu SH, et al. Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin Endocrinol 2012;77:47-50.
26. Chakaroun R, Raschpichler M, Klöting N, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2012;61: 706-14.
27. Tan BK, Chen J, Farhatullah S, et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009;58: 1971-7.
28. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010;21:660-7.
29. Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res 2010;25:222-34.
30. Sell H, Divoux A, Poitou C, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010;95:2892-6.
31. Bozaoglu K, Segal D, Sheilds KA, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican American Population. J Clin Endocrinol Metab 2009;94:3085-8.
32. Becker M, Rabe K, Lebherz C, et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high fat diet. Diabetes 2010;59: 2898-903.
33. Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009;58:2731-40.
34. Yang M, Yang G, Dong J, et al. Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Investig Med 2010;58:883-6.
35. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigenpresenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003;198:977-85.
36. Cho JK, Han TK, Kang HS. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol 2010;108:347-53.
37. Blüher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 2012;41:176-82.
38. Klöting N, Berndt J, Kralisch S, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006;339:430-6.
39. Youn BS, Klöting N, Kratzsch J, et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008;57:372-7.
40. Kukla M, Zwirska-Korczala K, Hartleb M, et al. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010;45:235-42.